# Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure

*PRI Rank #13 · Topics and Trends in Most Cited Heart Failure Treatment and Management Papers, Class of 2026*

*Canonical URL: https://pri.pepkio.com/top-papers/heart-failure-treatment-and-management/2026/rank-13*

| Field | Value |
| --- | --- |
| Rank | #13 |
| 18m citations | 78 |
| Journal | Journal of the American College of Cardiology |
| Year | 2024 |
| DOI | 10.1016/j.jacc.2024.02.009 |
| Corresponding authors | Zachary L. Cox |
| Institution | Lipscomb University, United States |

**Ranking page:** [Topics and Trends in Most Cited Heart Failure Treatment and Management Papers, Class of 2026](https://pri.pepkio.com/top-papers/heart-failure-treatment-and-management/2026)

**Paper link:** [10.1016/j.jacc.2024.02.009](https://doi.org/10.1016/j.jacc.2024.02.009)

## Topics

Dapagliflozin · Acute decompensated heart failure · SGLT2 inhibitors · Efficacy · Safety · Heart failure with reduced ejection fraction · Heart failure with preserved ejection fraction · Clinical trial design · Cardiovascular events · Heart failure hospitalization · All-Cause Mortality · Cardiovascular death · Natriuretic peptides · Renal function · diuresis · Natriuresis · Glycemic control · Type 2 diabetes · Randomized controlled trial · Patient-reported outcomes · Quality of life · Adverse events · Drug safety · Acute decompensated heart failure · In-hospital initiation of therapy · cardiorenal syndrome · Fluid Overload · Guideline-Directed Medical Therapy · Length of stay · Readmission rates

## Cite this ranking

```
Pepkio Research Index (PRI). Topics and Trends in Most Cited Heart Failure Treatment and Management Papers, Class of 2026. https://pri.pepkio.com/top-papers/heart-failure-treatment-and-management/2026. Accessed 2026-07-14.

Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459
```